Research Peptide APIs for Regulatory Market
| Product Name | US-DMF Time Point |
|---|---|
| Linaclotide | Before the end of 2019 |
| Ganirelix | Before the end of 2019 |
| Degarelix | Before the end of 2020 |
| Exenatide | Before the end of 2021 |
| Teduglutide | Before the end of 2021 |
| Cetrorelix | Before the end of 2021 |
| Semaglutide | Before the end of 2022 |
Chengdu Shengnuo Biotechnology Co.
Tel: 86-28-88203630
Fax: 86-28-88203630
Email: roleagh@gmail.com
QQ:2539328606
Facebook：[LEI LI](https://www.facebook.com/profile.php? id=100047326162701)
Linkedin: Roleagh
Chengdu Shengnuo Biotechnology Co., Ltd. has "Chengdu polypeptide drug engineering technology research center" in Chengdu, mainly engaged in polypeptide, polypeptide drug and beauty peptide research. Our zero defect has passed the FDA certification, and now it has become the first-class professional peptide drug and product development, technology transfer, technical service and peptide drug industry in the scale production and export of China's parks.